Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Australia, home to a world-class early phase clinical trial ecosystem
5 years ago
Transport Simulation Testing for Your Therapy is the Best Way to Assure FDA Expedited Program Approval
5 years ago
$48 Billion Is Lost to Avoidable Experiment Expenditure Every Year
6 years ago
BiTE® Platform and the Evolution Toward Off-The-Shelf Immuno-Oncology Approaches
6 years ago
How Australia Delivers Rapid Start-up and 43.5% Rebate for Early Phase Oncology Trials
6 years ago
Decentralized Clinical Trials: The future of clinical trials is now
6 years ago
A Fast Way to Curb Drug Development Costs? Make Failure a Strategy.
6 years ago
Taking Action to Ensure Clinical Trial Progress During COVID-19
6 years ago
Five strategies for mitigating the impact of COVID-19 on clinical trials
6 years ago
Venture Capital as a Strategic Partner: Fueling Innovation beyond Finance
6 years ago
Addressing Key Challenges of Lipid-Mediated Delivery Systems for mRNA through Innovation
6 years ago
Zhimeng Biopharma Announces the First-in-Human Dosing in Phase I Clinical Trial of ZM-H1505R Designed for the Treatment of Chronic Hepatitis B Virus Infection
6 years ago
Lessons for biotech and pharma from a doctor who chased his own cure
6 years ago
A New Frontier: The Inner Ear
6 years ago
2019 Trinity Drug Index Evaluates Actual Commercial Performance of Novel Drugs Approved in 2016
6 years ago
How to capitalise on a lean launch
6 years ago
Turning the corner on treating the root cause of sickle cell disease
6 years ago
Essential criteria biopharmaceutical investors seek when evaluating compounds and companies
6 years ago
Inventing Medicine by Accessing the Hidden Treasure in the Human Microbiome’s Dark Matter
6 years ago
Development of the Next Generation NKG2D CAR T-cell Manufacturing Process
6 years ago
Partner with the right bioanalytics firm at start-up to de-risk drug development
6 years ago
Conquering a silent killer: HDV and Eiger BioPharmaceuticals
6 years ago
Communicating the value of precision medicine
6 years ago
Practical implications of recent FDA guidance on immunogenicity risk assessments on your IND submissions
6 years ago
First page
Previous page
6
7
8
9
10
11
Next page
Last page